V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190010928 | 190007875 | 1.8 | 59.5 | Neo-adjuvant (N) | 2021-05-26 | 2021-12-31 | null | 02 | null | EW EUROEWING 2012 ARM A VAI | 101391675 |
| 190000680 | 190007876 | 0 | 38.6 | Palliative (P) | 2015-11-07 | 2017-04-10 | Ifosfamide | 02 | N | TRIAL | 101671483 |
| 190000808 | 190007877 | 1.68 | null | Adjuvant (A) | 2021-11-10 | 2021-12-15 | Doxorubicin + Methotrexate | 02 | null | CISPLATIN + CYTARABINE | 101186648 |
| 190002742 | 190007878 | 1.66 | 84.4 | 03 | 2018-08-27 | 2019-09-22 | Dox + HD Mtx (post PAM) | null | null | CAV | 100678585 |
| 190004163 | 190007879 | 1.6 | 76.2 | null | 2017-04-06 | 2017-04-13 | EW EuroEwing 2012 Arm B IE | 02 | null | EW EUROEWING 2012 ARM B IE | 101625605 |
| 190006089 | 190007880 | 1.75 | 58 | Palliative (P) | null | 2018-04-02 | Methotrexate High Dose (3g/m2) | 02 | N | METHOTREXATE | 100145043 |
| 190006487 | 190007882 | 1.59 | 96 | Palliative (P) | 2017-11-10 | 2018-02-01 | OST Euramos 1 Closed Trial - A | 02 | N | OST A | 101098407 |
| 190007060 | 190007884 | 0 | 63.4 | Curative (C) | 2016-07-05 | 2016-11-07 | ETOPOSIDE + IFOSFAMIDE | 02 | N | ETOPOSIDE + IFOSFAMIDE | 100854380 |
| 190007094 | 190007885 | 0 | 0 | Curative (C) | 2020-05-12 | 2020-10-12 | EW EuroEwing 2012 Arm B IE | 02 | null | EW EUROEWING 2012 ARM B IE | 101125341 |
| 190007264 | 190007886 | 1.75 | 38 | Palliative (P) | 2021-04-24 | 2021-07-14 | MAP + MIFAMURTIDE | 01 | null | TRIAL | 101834705 |
| 190009411 | 190007887 | 0 | 42.3 | Palliative (P) | 2019-10-19 | 2019-12-25 | ETOPOSIDE + IFOSFAMIDE | 01 | null | ETOPOSIDE + IFOSFAMIDE | 101440369 |
| 190010127 | 190007888 | 0 | 49.4 | Curative (C) | 2020-03-18 | 2021-02-07 | Irinotecan + Temozolomide | null | null | ETOPOSIDE | 100767437 |
| 190005101 | 190007911 | null | null | null | null | 2018-08-07 | null | null | null | MIFAMURTIDE | 101176674 |
| 190005213 | 190007914 | 1.46 | 70 | null | 2021-01-20 | 2021-03-17 | null | null | null | MIFAMURTIDE | 100948012 |
| 190006505 | 190007936 | null | null | null | null | 2017-11-08 | null | N | null | MIFAMURTIDE | 100621060 |
| 190007209 | 190007944 | null | null | null | null | 2017-10-06 | null | null | null | MIFAMURTIDE | 101138951 |
| 190008218 | 190007961 | null | null | null | null | 2021-12-28 | null | null | null | MIFAMURTIDE | 101377729 |
| 190008264 | 190007964 | 1.82 | 114 | Palliative (P) | 2018-07-16 | 2018-07-25 | Ifosfamide | 02 | null | CAPECITABINE + CARBOPLATIN | 100399288 |
| 190008359 | 190007966 | 1.8 | 71.7 | null | 2019-01-03 | 2019-07-17 | EW Rel rEECur Gemcitabine/Docetaxel | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101111083 |
| 190008417 | 190007967 | 1.74 | 51.5 | Palliative (P) | 2020-04-07 | 2020-04-14 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | CISPLATIN + GEMCITABINE | 100275307 |
| 190008489 | 190007968 | 1.8 | 66.8 | Adjuvant (A) | 2019-09-08 | 2020-04-24 | TEMOZOLOMIDE | 02 | N | FLUOROURACIL | 100544585 |
| 190008496 | 190007969 | 1.59 | 58.3 | Curative (C) | null | 2021-12-28 | Irinotecan + Modified De Gramont | null | null | FLUOROURACIL + IRINOTECAN | 100687980 |
| 190008572 | 190007970 | 1.83 | 82 | Neo-adjuvant (N) | 2022-01-28 | 2022-02-18 | Cisplatin 7 day | 01 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101317442 |
| 190008671 | 190007973 | 1.81 | 56.4 | Palliative (P) | 2020-01-11 | 2020-01-11 | Cisplatin + Radiotherapy | 02 | Y | CISPLATIN | 101855085 |
| 190008763 | 190007974 | 0 | 19.9 | null | 2020-12-06 | 2022-05-21 | LIPOSOMAL DOXORUBICIN | 02 | null | NOT MATCHED | 101179629 |
| 190008817 | 190007975 | 1.67 | 64.1 | Palliative (P) | 2020-01-30 | 2020-02-06 | Dinutuximab Beta | null | N | TRIAL UNSPECIFIED | 101375934 |
| 190008819 | 190007976 | 1.59 | 63.6 | Curative (C) | 2022-03-04 | 2022-03-04 | EURO-EWING | 01 | null | ABIRATERONE | 100543326 |
| 190008845 | 190007977 | 0 | 42 | null | 2017-06-18 | 2017-06-18 | EURO-EWING | 02 | null | GEMCITABINE | 100927741 |
| 190008952 | 190007978 | 1.57 | 81 | null | 2021-08-26 | 2022-04-09 | Epirubicin (weekly) | 02 | N | CARBOPLATIN + GEMCITABINE | 101825577 |
| 190008969 | 190007979 | 1.79 | 78.4 | null | null | 2021-09-26 | VAI (Ifos 3g/m2) | 02 | Y | EC | 101317787 |
| 190009035 | 190007981 | 1.58 | 75.3 | null | null | 2016-06-05 | Doxorubicin + Ifosfamide | 02 | null | CISPLATIN + ETOPOSIDE | 100827071 |
| 190009051 | 190007982 | 1.73 | 76 | Palliative (P) | 2020-12-31 | 2021-01-07 | OST Mifamurtide | 02 | N | CARBOPLATIN + GEMCITABINE | 100985989 |
| 190009215 | 190007985 | 1.78 | null | Palliative (P) | 2009-01-20 | 2019-05-11 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100645235 |
| 190009326 | 190007986 | 1.72 | 91.2 | Curative (C) | 2017-08-23 | 2017-08-29 | Bevacizumab 7.5mg/kg | 02 | null | DOCETAXEL | 100858772 |
| 190009329 | 190007987 | 1.66 | 71.7 | null | 2020-01-01 | 2020-02-18 | BEP 5 Day | 02 | N | TRANSPLANT CARBOPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + PACLITAXEL | 100062057 |
| 190009365 | 190007988 | 1.98 | 67.4 | Palliative (P) | null | 2017-11-24 | Cisplatin | null | null | CISPLATIN | 101285967 |
| 190009391 | 190007989 | null | 65.9 | Curative (C) | 2021-11-26 | 2022-03-12 | Carboplatin + Paclitaxel (weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 100856565 |
| 190009396 | 190007990 | 1.6 | 57 | Curative (C) | 2019-07-07 | 2019-08-01 | Cisplatin +Fluorouracil (2 wk) | 02 | N | CARBOPLATIN + ETOPOSIDE | 101470043 |
| 190009397 | 190007991 | 1.87 | 54 | Adjuvant (A) | null | 2017-02-11 | Cisplatin 7 day | 01 | null | CISPLATIN | 100097636 |
| 190009469 | 190007992 | null | 59.1 | Palliative (P) | 2018-07-19 | 2018-11-28 | EW EuroEwing 2012 Arm A VAC | 02 | N | CARBOPLATIN + ETOPOSIDE | 100346219 |
| 190009505 | 190007993 | 1.52 | 40 | Palliative (P) | null | 2019-06-12 | EW EuroEwing 2012 Arm A VIDE | 02 | null | FEC | 100154257 |
| 190009516 | 190007994 | 1.79 | 49.8 | null | 2021-12-11 | 2021-12-25 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101835370 |
| 190009548 | 190007995 | 1.69 | 82.7 | Palliative (P) | 2016-12-06 | 2017-01-05 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 100759437 |
| 190009576 | 190007996 | 0 | 46.3 | Neo-adjuvant (N) | 2018-04-07 | 2018-08-24 | OST Mifamurtide | 02 | null | EVEROLIMUS | 101692741 |
| 190009668 | 190007997 | 1.73 | 33.2 | null | 2020-06-01 | 2020-11-05 | PEMBROLIZUMAB | 02 | null | CISPLATIN + ETOPOSIDE | 100473939 |
| 190009699 | 190007998 | 1.63 | 115.3 | null | 2016-10-06 | 2016-10-06 | null | 02 | N | GEMCITABINE | 101276424 |
| 190009744 | 190007999 | 1.66 | 68.9 | Neo-adjuvant (N) | 2016-08-02 | 2016-08-14 | MAP | 02 | N | CAPECITABINE | 100054242 |
| 190009759 | 190008000 | 1.65 | 71.2 | 03 | 2020-11-25 | 2020-11-27 | MAP | N | N | NIVOLUMAB | 100644042 |
| 190009768 | 190008001 | 0 | 42.5 | null | 2022-02-07 | 2022-02-13 | CARBOPLATIN + FLUOROURACIL | 02 | N | DOXORUBICIN + METHOTREXATE | 101135474 |
| 190009780 | 190008002 | 1.7 | 49.7 | Palliative (P) | 2020-03-03 | 2020-03-12 | NB HRNBL-1 Isotretinoin | 01 | N | EW EUROEWING 2012 ARM A VAI | 100020687 |